Orion Oyj A (ORNAV) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.086x

Based on the latest financial reports, Orion Oyj A (ORNAV) has a cash flow conversion efficiency ratio of 0.086x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€79.50 Million ≈ $92.94 Million USD) by net assets (€919.60 Million ≈ $1.08 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Orion Oyj A - Cash Flow Conversion Efficiency Trend (2004–2024)

This chart illustrates how Orion Oyj A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Orion Oyj A (ORNAV) total liabilities for a breakdown of total debt and financial obligations.

Orion Oyj A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orion Oyj A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Celldex Therapeutics Inc NASDAQ:CLDX	-0.121x
Watsco Inc NYSE:WSO-B	0.108x
Hinge Health, Inc. NYSE:HNGE	0.169x
Bombardier Inc TO:BBD-A	-1.613x
Yunnan Botanee Bio-Technology Group Co Ltd SHE:300957	0.020x
ZhongAn Online P & C Insurance Co. Ltd F:1ZO	0.032x
China Railway Hi-tech Industry Corp Ltd SHG:600528	0.112x
Zhongshan Public Utilities Group Co Ltd SHE:000685	0.020x

Annual Cash Flow Conversion Efficiency for Orion Oyj A (2004–2024)

The table below shows the annual cash flow conversion efficiency of Orion Oyj A from 2004 to 2024. For the full company profile with market capitalisation and key ratios, see Orion Oyj A market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€1.00 Billion ≈ $1.17 Billion	€293.40 Million ≈ $343.02 Million	0.292x	+118.37%
2023-12-31	€890.10 Million ≈ $1.04 Billion	€119.00 Million ≈ $139.12 Million	0.134x	-72.05%
2022-12-31	€908.10 Million ≈ $1.06 Billion	€434.40 Million ≈ $507.86 Million	0.478x	+65.86%
2021-12-31	€747.90 Million ≈ $874.37 Million	€215.70 Million ≈ $252.18 Million	0.288x	-29.48%
2020-12-31	€731.30 Million ≈ $854.97 Million	€299.10 Million ≈ $349.68 Million	0.409x	+17.72%
2019-12-31	€779.40 Million ≈ $911.20 Million	€270.80 Million ≈ $316.59 Million	0.347x	+16.33%
2018-12-31	€773.10 Million ≈ $903.84 Million	€230.90 Million ≈ $269.95 Million	0.299x	-11.12%
2017-12-31	€679.70 Million ≈ $794.64 Million	€228.40 Million ≈ $267.02 Million	0.336x	-13.52%
2016-12-31	€641.10 Million ≈ $749.51 Million	€249.10 Million ≈ $291.22 Million	0.389x	-9.32%
2015-12-31	€594.90 Million ≈ $695.50 Million	€254.90 Million ≈ $298.00 Million	0.428x	-25.64%
2014-12-31	€514.90 Million ≈ $601.97 Million	€296.70 Million ≈ $346.87 Million	0.576x	+37.60%
2013-12-31	€513.90 Million ≈ $600.80 Million	€215.20 Million ≈ $251.59 Million	0.419x	-3.14%
2012-12-31	€511.20 Million ≈ $597.65 Million	€221.00 Million ≈ $258.37 Million	0.432x	+8.68%
2011-12-31	€500.00 Million ≈ $584.55 Million	€198.90 Million ≈ $232.54 Million	0.398x	-11.08%
2010-12-31	€467.40 Million ≈ $546.44 Million	€209.10 Million ≈ $244.46 Million	0.447x	-3.99%
2009-12-31	€439.10 Million ≈ $513.35 Million	€204.60 Million ≈ $239.20 Million	0.466x	+35.07%
2008-12-31	€418.60 Million ≈ $489.39 Million	€144.40 Million ≈ $168.82 Million	0.345x	+2.25%
2007-12-31	€447.30 Million ≈ $522.94 Million	€150.90 Million ≈ $176.42 Million	0.337x	+83.36%
2006-12-31	€443.50 Million ≈ $518.50 Million	€81.60 Million ≈ $95.40 Million	0.184x	-38.23%
2005-12-31	€581.80 Million ≈ $680.19 Million	€173.30 Million ≈ $202.61 Million	0.298x	-22.89%
2004-12-31	€479.70 Million ≈ $560.82 Million	€185.30 Million ≈ $216.64 Million	0.386x	--

About Orion Oyj A

HE:ORNAV Finland Drug Manufacturers - General

Market Cap

$2.54 Billion

€2.17 Billion EUR

Market Cap Rank

#5448 Global

#23 in Finland

Share Price

€68.10

Change (1 day)

+3.03%

52-Week Range

€54.10 - €74.80

All Time High

€74.80